The inclusion for the Kawasaki Disease Coronary Artery Aneurysm Prevention Trial has come to an end.
This pivotal trial explores the addition of corticosteroids to the standard of care for Kawasaki disease within the conect4children project.
Europe wide 55 sites were opened across 12 countries and a total of 103 participants were recruited.
We want to give a huge thank you to all our participating sites. Your hard work and dedication have been key to making this study a success. Together, we have made a real difference in our ongoing efforts to improve the treatment of Kawasaki Disease.
